Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
This study has been completed.
Study NCT00061022   Information provided by AstraZeneca
First Received: May 20, 2003   Last Updated: March 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebral Stroke
Stroke, Acute
Cerebrovascular Stroke
Ischemic Attack, Transient
Additional conditions recognized in this trial
Cerebral Infarction
Ischemia
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
NXY-059
Additional drug interventions recognized in this trial
Disufenton sodium
More general drug interventions related to this trial
Antioxidants
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services